Related Experiment Video
Updated: Aug 9, 2026

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
Published on: July 27, 2016
Lesions in ryanodine channels in smooth muscle cells exposed to oxidized low density lipoprotein
H Massaeli1, J A Austria, G N Pierce
1Division of Stroke and Vascular Disease, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada.
Abstract:
The purpose of the present investigation was to investigate the subcellular basis responsible for the loss of vasoreactivity in atherosclerotic vessels. We have chosen to focus on the potential of oxidized low density lipoprotein (oxLDL), an important atherogenic agent, to alter sarcoplasmic reticulum (SR) structure and function. Vascular smooth muscle cells (VSMCs) were exposed for 1 to 6 days to low concentrations of minimally oxidized LDL. ATP was used to probe SR function in VSMCs. ATP can increase [Ca(2+)](i) in control VSMCs because of a release of Ca(2+) from the SR. However, after chronic exposure to oxLDL, cells lose their ability to increase [Ca(2+)](i) in response to ATP. These cells also exhibit a depressed rise in [Ca(2+)](i) after exposure to ryanodine. These effects were associated with a decreased immunoreactivity for the ryanodine-sensitive Ca(2+)-release channels in the SR of oxLDL-treated cells. Immunohistochemical analysis of aortic sections obtained from rabbits fed a cholesterol-supplemented diet revealed a significant decrease in the immunoreactivity for ryanodine channels in the plaque and in the medial layer underlying the plaque. In summary, our data identify oxLDL as a component within the atherosclerotic milieu capable of inducing a decrease in smooth muscle ryanodine channel density. This alteration is associated with a significant defect in the ability of the SR within the smooth muscle cell to regulate Ca(2+). These lesions may contribute to the altered vasoreactivity exhibited by atherosclerotic vessels.
Insights
Oxidized low-density lipoprotein (oxLDL) impairs sarcoplasmic reticulum (SR) function in vascular smooth muscle cells. This leads to reduced calcium (Ca2+) regulation and contributes to vasoreactivity loss in atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Cellular Physiology
- Atherosclerosis Research
Background:
- Atherosclerosis is characterized by altered vasoreactivity in blood vessels.
- Oxidized low-density lipoprotein (oxLDL) is a key atherogenic factor implicated in disease progression.
Purpose of the Study:
- To investigate the subcellular mechanisms underlying vasoreactivity loss in atherosclerosis.
- To determine the role of oxLDL in altering sarcoplasmic reticulum (SR) structure and function in vascular smooth muscle cells (VSMCs).
Main Methods:
- VSMCs were exposed to oxLDL to assess changes in SR function.
- Calcium (Ca2+) signaling in response to ATP and ryanodine was measured.
- Immunohistochemistry was used to evaluate ryanodine channel density in VSMCs and aortic sections.
Main Results:
- Chronic oxLDL exposure in VSMCs abolished the ATP-induced Ca2+ release from the SR.
- Oxidized LDL-treated cells showed a diminished Ca2+ rise upon ryanodine exposure.
- A significant decrease in ryanodine-sensitive Ca2+-release channels was observed in oxLDL-exposed VSMCs and atherosclerotic rabbit aortas.
Conclusions:
- Oxidized low-density lipoprotein (oxLDL) reduces ryanodine channel density in vascular smooth muscle.
- This reduction impairs SR-mediated Ca2+ regulation within smooth muscle cells.
- These cellular defects likely contribute to the impaired vasoreactivity observed in atherosclerotic vessels.
Related Concept Videos
Inflammation
Antihypertensive Drugs: Action of Calcium Channel Blockers
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
Atherosclerosis I: Introduction

